Novobiocin Hydrate is a bacteriostatic antibiotic in the nitrobenzoic acid class, primarily utilized for treating infections caused by susceptible Gram-positive bacteria, including Staphylococcus aureus… Read more
Novobiocin Hydrate is a bacteriostatic antibiotic in the nitrobenzoic acid class, primarily utilized for treating infections caused by susceptible Gram-positive bacteria, including Staphylococcus aureus and Streptococcus species. It operates by inhibiting DNA gyrase, an essential enzyme that facilitates bacterial DNA replication and transcription. Analytical laboratories rely on high-quality reference standards of Novobiocin Hydrate, along with its associated pharmacopeial and non-pharmacopeial impurities, to ensure accurate pharmaceutical analysis. These compounds are critical for conducting robust impurity profiling and method validation, allowing researchers to monitor degradation products and ensure the consistency of active pharmaceutical ingredients. Furthermore, stable isotope labelled compounds are indispensable in advanced mass spectrometry-based assays, providing internal standards that enhance precision and reliability during quality control and pharmacokinetic studies.